Cash flow Scope Fluidics S.A.

Stocks

SCP

PLSCPFL00018

Biotechnology & Medical Research

Market Closed - Warsaw S.E. Other stock markets 11:55:50 2026-06-26 EDT			5-day change	1st Jan Change
118.40 ^PLN	0.00%		-3.74%	-13.07%

05-27	Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip'	RE
05-15	Scope Fluidics Q1 net loss at 13.5 million zlotys	RE

0a04.g5woMl2eS9ztztxhH9YwdqxyjBEo3wWN7Y-fv8ZMM7Y.zu9MUBPGPu2e9rg2XudVHu0x7Utr7Dfrr_7R86Ifa87N6FALH6sIpZWGjQ

Published financial data: SCOPE FLUIDICS S.A.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	-	-	404K	516K	131K
Total Revenues	-	-	404K	516K	131K
Cost of Goods Sold, Total	1.28M	656K	872K	1.89M	1.31M
Gross Profit	-1.28M	-656K	-468K	-1.37M	-1.18M
Selling General & Admin Expenses, Total	8.91M	9.45M	23.35M	23.74M	28.14M
Depreciation & Amortization - (IS)	177K	414K	641K	1.08M	1.51M
Other Operating Expenses	-2.97M	-272K	771K	2.49M	1.66M
Other Operating Expenses, Total	6.11M	9.59M	24.77M	27.31M	31.31M
Operating Income	-7.4M	-10.25M	-25.23M	-28.68M	-32.49M
Interest Expense, Total	-25	-2.61M	-743K	-278K	-210K
Interest And Investment Income	23.46K	-	4.5M	9.98M	3.26M
Net Interest Expenses	23.44K	-2.61M	3.75M	9.7M	3.05M
Currency Exchange Gains (Loss)	-	-161K	6.63M	-528K	4M
Other Non Operating Income (Expenses)	-10.1K	1.3M	-8.6M	857K	1.29M
EBT, Excl. Unusual Items	-7.39M	-11.72M	-23.45M	-18.66M	-24.14M
Gain (Loss) On Sale Of Assets	-35.16K	-	419M	-	110M
Asset Writedown	-	-	-	-	-
EBT, Incl. Unusual Items	-7.42M	-11.72M	395M	-18.66M	85.4M
Income Tax Expense	-	-1K	69.05M	129K	19.98M
Earnings From Continuing Operations	-7.42M	-11.72M	326M	-18.78M	65.42M
Earnings Of Discontinued Operations	-	-4.91M	-7.57M	-	-
Net Income to Company	-7.42M	-16.64M	318M	-18.78M	65.42M
Minority Interest	-	-	-	-	-
Net Income - (IS)	-7.42M	-16.64M	318M	-18.78M	65.42M
Net Income to Common Incl Extra Items	-7.42M	-16.64M	318M	-18.78M	65.42M
Net Income to Common Excl. Extra Items	-7.42M	-11.72M	326M	-18.78M	65.42M
Per Share Items
Net EPS - Basic	-2.76	-6.19	118.34	-6.89	24
Basic EPS - Continuing Operations	-2.76	-4.36	121.16	-6.89	24
Basic Weighted Average Shares Outstanding	2.69M	2.69M	2.69M	2.73M	2.73M
Net EPS - Diluted	-2.76	-6.19	118.01	-6.89	24
Diluted EPS - Continuing Operations	-2.76	-4.36	120.82	-6.89	24
Diluted Weighted Average Shares Outstanding	2.69M	2.69M	2.7M	2.73M	2.73M
Normalized Basic EPS	-1.72	-2.73	-5.45	-4.28	-5.54
Normalized Diluted EPS	-1.72	-2.73	-5.43	-4.28	-5.54
Dividend Per Share	-	-	85.57	-	-
Payout Ratio	-	-	-	-1.24K	-
Supplemental Items
EBITDA	-6.41M	-9.84M	-24.77M	-28.42M	-31.79M
EBITA	-6.56M	-10.25M	-25.23M	-28.65M	-31.82M
EBIT	-7.4M	-10.25M	-25.23M	-28.68M	-32.49M
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	-	0.01	17.48	-0.69	23.39
Current Domestic Taxes	-	-	-	-	19.73M
Total Current Taxes	-	-	69.06M	-	19.73M
Deferred Domestic Taxes	-	-	-	-	245K
Total Deferred Taxes	-	-1K	-11K	-	245K
Normalized Net Income	-4.62M	-7.33M	-14.66M	-11.66M	-15.09M
Interest on Long-Term Debt	-	24K	68K	263K	201K
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	-	3.05M	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	6.3M	1.37M
Stock-Based Comp., Other (Total)	-	3.84M	11.86M	-	-
Total Stock-Based Compensation	-	3.84M	11.86M	6.3M	1.37M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	25.71M	18.09M	332M	66.29M	129M
Trading Asset Securities, Total	-	-	-	20.9M	22.19M
Total Cash And Short Term Investments	25.71M	18.09M	332M	87.19M	151M
Accounts Receivable, Total	-	-	-	-	16K
Other Receivables	1.63M	1.01M	4.28M	2.01M	2.7M
Total Receivables	1.63M	1.01M	4.28M	2.01M	2.72M
Inventory	442K	287K	673K	710K	1.76M
Prepaid Expenses	76.22K	37K	35K	39K	56K
Other Current Assets, Total	124K	26.27M	109K	553K	756K
Total Current Assets	27.98M	45.7M	337M	90.5M	156M
Gross Property Plant And Equipment	1.6M	2.63M	3.24M	4.66M	7.42M
Accumulated Depreciation	-1.03M	-739K	-506K	-563K	-1.23M
Net Property Plant And Equipment	567K	1.9M	2.74M	4.1M	6.19M
Goodwill	811K	-	-	-	-
Other Intangibles, Total	181K	74K	21K	107K	136K
Deferred Charges Long-Term	-	4.91M	6.05M	6.27M	9.6M
Other Long-Term Assets, Total	11.76M	160K	655K	508K	496K
Total Assets	41.31M	52.73M	346M	101M	173M
Liabilities
Accounts Payable, Total	620K	305K	525K	1.47M	1.54M
Accrued Expenses, Total	1.22M	933K	3.2M	2.5M	5.99M
Current Portion of Leases	-	357K	571K	873K	944K
Current Income Taxes Payable	659K	-	-	-	-
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	-	7.32M	650K	1.31M	2.88M
Total Current Liabilities	2.49M	8.92M	4.95M	6.15M	11.36M
Long-Term Debt	-	11.96M	-	-	-
Long-Term Leases	-	1.15M	1.88M	1.54M	648K
Unearned Revenue Non Current	5.72M	-	-	-	-
Deferred Tax Liability Non Current	-	11K	-	171K	416K
Other Non Current Liabilities	-	16.11M	6.35M	12.7M	14.09M
Total Liabilities	8.22M	38.15M	13.18M	20.56M	26.52M
Common Stock, Total	269K	269K	273K	273K	273K
Additional Paid In Capital	61.94M	61.94M	71.47M	71.47M	71.47M
Retained Earnings	-29.12M	-57.26M	261M	9.19M	50.9M
Comprehensive Income and Other	-	9.63M	-	-	23.71M
Total Common Equity	33.09M	14.58M	333M	80.93M	146M
Total Equity	33.09M	14.58M	333M	80.93M	146M
Total Liabilities And Equity	41.31M	52.73M	346M	101M	173M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.69M	2.69M	2.73M	2.73M	2.73M
ECS Total Common Shares Outstanding	2.69M	2.69M	2.73M	2.73M	2.73M
Book Value / Share	12.32	5.43	122.15	29.69	53.69
Tangible Book Value	32.09M	14.51M	333M	80.82M	146M
Tangible Book Value Per Share	11.95	5.4	122.14	29.65	53.64
Total Debt	0	13.47M	2.46M	2.41M	1.59M
Net Debt	-25.71M	-4.62M	-329M	-84.78M	-150M
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	440K	166K	615K	648K	492K
Inventories - Work In Process, Total	-	-	-	-	1.14M
Inventories - Others	2.53K	121K	58K	62K	134K
Machinery, Total	1.54M	1.09M	763K	1.94M	3.56M
Full Time Employees	48	79	30	40	63

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-7.42M	-16.64M	318M	-18.78M	65.42M
Depreciation & Amortization - CF	145K	414K	664K	1.05M	847K
Amortization of Goodwill and Intangible Assets - (CF)	840K	-	-	29K	665K
Depreciation & Amortization, Total	986K	414K	664K	1.08M	1.51M
(Gain) Loss From Sale Of Asset	35.19K	-51K	-418M	-	-111M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-902K	-
Stock-Based Compensation (CF)	-	3.84M	-	-	-
Net Cash From Discontinued Operations	-	-10.26M	-7.11M	-	-
Other Operating Activities, Total	-3.58M	177K	86.67M	-9.54M	17.09M
Change In Accounts Receivable	-565K	764K	-1.27M	-98K	-978K
Change In Inventories	-442K	155K	-385K	-37K	-1.05M
Change In Accounts Payable	-	-1.25M	-7.41M	8.56M	3.77M
Change in Other Net Operating Assets	-4.97M	656K	321K	663K	-36K
Cash from Operations	-15.96M	-22.19M	-28.16M	-19.06M	-25.1M
Capital Expenditure	-484K	-121K	-155K	-1.93M	-3.24M
Sale of Property, Plant, and Equipment	-	51K	110K	-	-
Divestitures	-	-	443M	-	120M
Sale (Purchase) of Intangible assets	-	-4.79M	-1.14M	-222K	-3.32M
Investment in Marketable and Equity Securities, Total	-	-	-	-20M	-
Other Investing Activities, Total	-	1.52M	-70.24M	10.12M	-24.14M
Cash from Investing	-484K	-3.34M	371M	-12.03M	88.9M
Short Term Debt Issued, Total	-	-	14.52M	-	-
Long-Term Debt Issued, Total	-	18.51M	-	-	-
Total Debt Issued	-	18.51M	14.52M	-	-
Short Term Debt Repaid, Total	-	-	-34.32M	-	-
Long-Term Debt Repaid, Total	-	-350K	-470K	-703K	-919K
Total Debt Repaid	-	-350K	-34.79M	-703K	-919K
Issuance of Common Stock	20.29M	-	4K	-	-
Common Dividends Paid	-	-	-	-233M	-
Common & Preferred Stock Dividends Paid	-	-	-	-233M	-
Other Financing Activities, Total	3.58M	-258K	-10.01M	-263K	-200K
Cash from Financing	23.87M	17.91M	-30.28M	-234M	-1.12M
Net Change in Cash	7.43M	-7.62M	313M	-265M	62.68M
Supplemental Items
Cash Interest Paid	-	-	10.04M	263K	200K
Cash Income Tax Paid (Refund)	-	-	72.02M	-2.12M	19.68M
Levered Free Cash Flow	-4.54M	-27.96M	5.48M	-10.19M	-20.96M
Unlevered Free Cash Flow	-4.54M	-26.33M	5.95M	-10.02M	-20.83M
Change In Net Working Capital	417K	19.27M	-10.49M	-2.68M	-3.16M
Net Debt Issued / Repaid	-	18.16M	-20.27M	-703K	-919K

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-13.46	-13.53	-7.91	-8.01	-14.8
Return on Total Capital	-17.35	-24.2	-8.87	-8.56	-17.56
Return On Equity %	-27.84	-61.77	191.96	-9.08	57.57
Return on Common Equity	-27.84	-61.77	191.96	-9.08	57.57
Margin Analysis
Gross Profit Margin %	-	-	-115.84	-265.89	-901.53
SG&A Margin	-	-	5.78K	4.6K	21.48K
EBITDA Margin %	-	-	-6.13K	-5.51K	-24.27K
EBITA Margin %	-	-	-6.25K	-5.55K	-24.29K
EBIT Margin %	-	-	-6.25K	-5.56K	-24.8K
Income From Continuing Operations Margin %	-	-	80.71K	-3.64K	49.94K
Net Income Margin %	-	-	78.83K	-3.64K	49.94K
Net Avail. For Common Margin %	-	-	80.71K	-3.64K	49.94K
Normalized Net Income Margin	-	-	-3.63K	-2.26K	-11.52K
Levered Free Cash Flow Margin	-	-	1.36K	-1.98K	-16K
Unlevered Free Cash Flow Margin	-	-	1.47K	-1.94K	-15.9K
Asset Turnover
Asset Turnover	-	-	0	0	0
Fixed Assets Turnover	-	-	0.17	0.15	0.03
Inventory Turnover (Average Inventory)	-	1.8	1.82	2.73	1.06
Short Term Liquidity
Current Ratio	11.22	5.13	68.03	14.71	13.77
Quick Ratio	10.96	2.14	67.87	14.5	13.54
Operating Cash Flow to Current Liabilities	-6.4	-2.49	-5.69	-3.1	-2.21
Days Outstanding Inventory (Average Inventory)	-	202.81	200.92	133.68	344.66
Average Days Payable Outstanding	-	336.95	120.41	189.14	233.34
Long Term Solvency
Total Debt/Equity	-	92.37	0.74	2.98	1.09
Total Debt / Total Capital	-	48.02	0.73	2.89	1.08
LT Debt/Equity	-	89.93	0.57	1.9	0.44
Long-Term Debt / Total Capital	-	46.75	0.56	1.84	0.44
Total Liabilities / Total Assets	19.9	72.35	3.81	20.26	15.34
EBIT / Interest Expense	-296K	-3.93	-33.96	-103.18	-154.7
EBITDA / Interest Expense	-257K	-3.77	-33.07	-99.29	-147.5
(EBITDA - Capex) / Interest Expense	-276K	-3.81	-33.28	-106.23	-162.9
Total Debt / EBITDA	-	-1.37	-0.1	-0.09	-0.05
Net Debt / EBITDA	4.01	0.47	13.4	3.07	4.83
Total Debt / (EBITDA - Capex)	-	-1.35	-0.1	-0.08	-0.05
Net Debt / (EBITDA - Capex)	3.73	0.46	13.31	2.87	4.37
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	-	27.72	-74.61
Gross Profit, 1 Yr. Growth %	183.98	-31.16	-28.66	193.16	-13.92
EBITDA, 1 Yr. Growth %	19.43	-13.9	147.36	13.42	11.87
EBITA, 1 Yr. Growth %	3.62	-12.65	146.21	13.55	12.09
EBIT, 1 Yr. Growth %	16.9	-12.65	146.21	13.67	13.26
Earnings From Cont. Operations, 1 Yr. Growth %	17.79	3.9	-2.88K	-105.76	-448.26
Net Income, 1 Yr. Growth %	17.79	25.06	-2.01K	-105.9	-448.26
Normalized Net Income, 1 Yr. Growth %	17.23	2.97	100.06	-20.44	29.42
Diluted EPS Before Extra, 1 Yr. Growth %	1.53	-0.82	-2.87K	-105.7	-448.26
Inventory, 1 Yr. Growth %	-	-35.07	134.49	5.5	148.03
Net Property, Plant and Equip., 1 Yr. Growth %	23.25	-5.67	44.49	49.74	50.49
Total Assets, 1 Yr. Growth %	50.73	25.74	556.43	-70.68	70.33
Tangible Book Value, 1 Yr. Growth %	72.71	-37.44	4.9K	-75.73	80.91
Common Equity, 1 Yr. Growth %	63.64	-37.61	4.84K	-75.69	80.84
Cash From Operations, 1 Yr. Growth %	52.29	129.62	31.78	-32.32	31.73
Capital Expenditures, 1 Yr. Growth %	41.82	-67.47	28.1	1.14K	67.7
Levered Free Cash Flow, 1 Yr. Growth %	107.28	241.97	-128.38	-285.93	105.64
Unlevered Free Cash Flow, 1 Yr. Growth %	107.4	223.48	-132.16	-268.49	107.89
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-	-	-43.06
Gross Profit, 2 Yr. CAGR %	46.76	24.53	-29.92	44.62	58.86
EBITDA, 2 Yr. CAGR %	41.19	20.16	47.25	68.47	12.64
EBITA, 2 Yr. CAGR %	25.15	20.03	46.65	67.21	12.3
EBIT, 2 Yr. CAGR %	32.92	20.03	46.65	67.29	13.46
Earnings From Cont. Operations, 2 Yr. CAGR %	34.98	29.14	437.59	26.59	-55.21
Net Income, 2 Yr. CAGR %	34.98	45	389.32	6.27	-54.68
Normalized Net Income, 2 Yr. CAGR %	34.52	29.19	43.51	26.16	1.47
Diluted EPS Before Extra, 2 Yr. CAGR %	25.31	19.81	424.01	25.67	-55.43
Inventory, 2 Yr. CAGR %	-	-	23.39	57.29	61.76
Net Property, Plant and Equip., 2 Yr. CAGR %	45.32	0.86	16.74	47.09	50.33
Total Assets, 2 Yr. CAGR %	72.34	39.27	187.3	38.73	-29.33
Tangible Book Value, 2 Yr. CAGR %	76.01	-2.29	278.9	248.26	-33.73
Common Equity, 2 Yr. CAGR %	60.74	-2.09	277.44	246.57	-33.7
Cash From Operations, 2 Yr. CAGR %	72.24	100.83	70.7	-5.56	-5.58
Capital Expenditures, 2 Yr. CAGR %	149.12	-41.29	-35.45	299.28	356.85
Levered Free Cash Flow, 2 Yr. CAGR %	29.06	145.17	-18.12	-27.36	95.54
Unlevered Free Cash Flow, 2 Yr. CAGR %	29.06	138.47	-14.53	-26.39	87.16
Compound Annual Growth Rate Over Three Years
Gross Profit, 3 Yr. CAGR %	47.34	3.23	3.43	12.92	21.65
EBITDA, 3 Yr. CAGR %	26.59	45.13	53.77	35.5	46.97
EBITA, 3 Yr. CAGR %	16.84	34.76	52.51	34.67	45.89
EBIT, 3 Yr. CAGR %	21.63	34.76	52.51	34.71	46.9
Earnings From Cont. Operations, 3 Yr. CAGR %	21.16	42.24	259.31	18.52	77.38
Net Income, 3 Yr. CAGR %	21.16	59.84	242.72	12.19	57.85
Normalized Net Income, 3 Yr. CAGR %	21.45	42.15	49.46	17.89	27.24
Diluted EPS Before Extra, 3 Yr. CAGR %	15.12	35.37	241.26	16.13	76.51
Inventory, 3 Yr. CAGR %	145.17	-	-	17.11	83.07
Net Property, Plant and Equip., 3 Yr. CAGR %	21.65	91.85	13.69	26.84	48.36
Total Assets, 3 Yr. CAGR %	30.25	55.94	133.51	34.26	48.55
Tangible Book Value, 3 Yr. CAGR %	33.19	11.88	179.82	51.61	179.95
Common Equity, 3 Yr. CAGR %	25.15	4.43	179.73	51.29	179.01
Cash From Operations, 3 Yr. CAGR %	47.91	60.39	72.33	25.4	5.52
Capital Expenditures, 3 Yr. CAGR %	32.89	15.8	-23.85	73.09	199.02
Levered Free Cash Flow, 3 Yr. CAGR %	41.22	117.29	5.62	7.62	2.76
Unlevered Free Cash Flow, 3 Yr. CAGR %	41.53	112.99	8.7	7.17	4.05
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	195.27	-	-
Gross Profit, 5 Yr. CAGR %	-18.22	27.61	3.11	18.14	22.8
EBITDA, 5 Yr. CAGR %	68.38	22.09	50.94	54.6	36.08
EBITA, 5 Yr. CAGR %	58.51	22.31	43.74	46.91	34.93
EBIT, 5 Yr. CAGR %	62.38	21.64	43.74	46.94	35.49
Earnings From Cont. Operations, 5 Yr. CAGR %	54.91	27.2	139.1	35.76	56.23
Net Income, 5 Yr. CAGR %	63.38	36.43	137.98	35.76	52.58
Normalized Net Income, 5 Yr. CAGR %	70.03	25.01	41.58	35.52	28.01
Diluted EPS Before Extra, 5 Yr. CAGR %	-	22.99	131.66	31.4	51.17
Inventory, 5 Yr. CAGR %	-	-	86.29	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	-0.76	43.22	54.13	72.51	27.14
Total Assets, 5 Yr. CAGR %	34.26	52.14	79.28	48.81	44.77
Tangible Book Value, 5 Yr. CAGR %	51.77	57.15	89.62	50.81	57.27
Common Equity, 5 Yr. CAGR %	37.63	21.2	81.56	44.59	57.27
Cash From Operations, 5 Yr. CAGR %	97.15	41.84	41.69	28.79	35.47
Capital Expenditures, 5 Yr. CAGR %	-32.56	97.21	-5.54	89.99	55.92
Levered Free Cash Flow, 5 Yr. CAGR %	-	54.15	27.74	30.19	35.13
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	52.32	30.01	29.74	35.09